Intercontinental Exchange, Inc.

0JC3.L·LSE
Compare
175.37+1.08 (+0.62%)today
As of Nov 5, 11:20 AM GMT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close174.29
Open174.12
Day range173.25176.95
52-week range119.11176.95
Off day high−0.89%
Off 52-week high−0.89%
Volume242
Avg. volume (3M)3.03K
Market cap—
EPS (TTM)7.20
Forward P/E—
P/E ratio (TTM)24.35
Dividend yield1.17% (2.04)
Beta (5Y)0.84
Shares outstanding569.58M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin38.14%

Against its peers

Compare in full ›
0JC3.L SOU.F 0388.HK CBOE 0QVJ.IL CXI.TO
Market cap — 15.42B 498.77B 36.02B 18.43B 196.82M
P/E (TTM) 24.4 33.5 25.2 24.6 47.6 10.3
Forward P/E — — 24.7 22.3 — 11.1
Price/book 3.3 9.3 8.2 6.1 4.8 1.6
Dividend yield 1.17% 2.36% 3.87% 1.00% 3.35% —
1-year change +18.72% +27.14% −9.35% +36.64% +40.34% +39.14%
Today +0.62% +2.13% +2.76% +0.27% +1.49% +1.24%

The closest companies by business. Prices may be delayed up to 15 min.

Latest news

All 0JC3.L news ›
Stock Titan·Positive

Intercontinental Exchange Q3 net revenue rises 15%

SEGG Media Reports More Than 1,500% Year-Over-Year Revenue Growth in Second Quarter, Driven by Veloce uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the…

ICE
Stock Titan·Positive

Intercontinental Exchange Q3 profit rises to $940M

uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue…

From the 4Search news index, newest first.

In the news

87mentions in 30 days
87with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 87 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance